HomeBBIO • NASDAQ
add
BridgeBio Pharma Inc
Previous close
$23.24
Day range
$22.47 - $23.65
Year range
$21.68 - $44.32
Market cap
4.40B USD
Avg Volume
1.67M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 2.73M | -33.22% |
Operating expense | 189.26M | 17.62% |
Net income | -162.04M | 8.45% |
Net profit margin | -5.93K | -37.09% |
Earnings per share | -1.08 | 0.54% |
EBITDA | -185.59M | -19.14% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 266.32M | -50.98% |
Total assets | 664.98M | 1.52% |
Total liabilities | 1.88B | 1.87% |
Total equity | -1.22B | — |
Shares outstanding | 188.99M | — |
Price to book | -3.57 | — |
Return on assets | -64.11% | — |
Return on capital | -80.76% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -162.04M | 8.45% |
Cash from operations | -180.57M | -24.33% |
Cash from investing | 38.23M | 1.44% |
Cash from financing | 707.00K | -99.77% |
Net change in cash | -141.63M | -171.00% |
Free cash flow | -109.35M | -32.75% |
About
CEO
Founded
2015
Headquarters
Website
Employees
553
